These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14642972)

  • 1. Muscarinic mechanisms of antipsychotic atypicality.
    Bymaster FP; Felder CC; Tzavara E; Nomikos GG; Calligaro DO; Mckinzie DL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1125-43. PubMed ID: 14642972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release.
    Johnson DE; Nedza FM; Spracklin DK; Ward KM; Schmidt AW; Iredale PA; Godek DM; Rollema H
    Eur J Pharmacol; 2005 Jan; 506(3):209-19. PubMed ID: 15627430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor pharmacology of neuroleptics: relation to clinical effects.
    Richelson E
    J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacology of neuroleptics: focus on new generation compounds.
    Richelson E
    J Clin Psychiatry; 1996; 57 Suppl 11():4-11. PubMed ID: 8941166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural pharmacology of the new generation of antipsychotic agents.
    Moore NA
    Br J Psychiatry Suppl; 1999; (38):5-11. PubMed ID: 10884895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain.
    Terry AV; Gearhart DA; Mahadik SP; Warsi S; Waller JL
    Neuroscience; 2006 Jul; 140(4):1277-87. PubMed ID: 16626873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic aspects of schizophrenia.
    Tandon R
    Br J Psychiatry Suppl; 1999; (37):7-11. PubMed ID: 10211133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic m4 receptor activation by some atypical antipsychotic drugs.
    Zeng XP; Le F; Richelson E
    Eur J Pharmacol; 1997 Mar; 321(3):349-54. PubMed ID: 9085047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.
    Bymaster FP; Felder CC
    Mol Psychiatry; 2002; 7 Suppl 1():S57-63. PubMed ID: 11986996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
    Bymaster FP; Rasmussen K; Calligaro DO; Nelson DL; DeLapp NW; Wong DT; Moore NA
    J Clin Psychiatry; 1997; 58 Suppl 10():28-36. PubMed ID: 9265914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
    Bolden C; Cusack B; Richelson E
    J Pharmacol Exp Ther; 1992 Feb; 260(2):576-80. PubMed ID: 1346637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition.
    Tzavara ET; Bymaster FP; Nomikos GG
    Mol Psychiatry; 2006 Jul; 11(7):619-21. PubMed ID: 16801977
    [No Abstract]   [Full Text] [Related]  

  • 16. Inverse agonist properties of atypical antipsychotic drugs.
    Akam E; Strange PG
    Biochem Pharmacol; 2004 Jun; 67(11):2039-45. PubMed ID: 15135301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone.
    Andreasen JT; Andersen KK; Nielsen EØ; Mathiasen L; Mirza NR
    Behav Brain Res; 2006 Feb; 167(1):118-27. PubMed ID: 16225935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in-vivo muscarinic cholinergic receptor availability in patients treated with clozapine and olanzapine.
    Raedler TJ
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):275-80. PubMed ID: 16945161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.
    Davies MA; Setola V; Strachan RT; Sheffler DJ; Salay E; Hufeisen SJ; Roth BL
    Pharmacogenomics J; 2006; 6(1):42-51. PubMed ID: 16314884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
    Davies MA; Compton-Toth BA; Hufeisen SJ; Meltzer HY; Roth BL
    Psychopharmacology (Berl); 2005 Apr; 178(4):451-60. PubMed ID: 15765260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.